Welsbie, Derek S

Development of a second-generation antiandrogen for treatment of advanced prostate cancer.

Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science

Prostate Cancer Treatment and ResearchHeterocyclic Compound Synthesis and Bioactivity

Cited by 2,292

Molecular determinants of resistance to antiandrogen therapy

Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine

Prostate Cancer Treatment and ResearchEstrogen and related hormone effects

Cited by 2,278

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine

PI3K/AKT/mTOR signaling in cancerCancer, Hypoxia, and Metabolism

Cited by 604

Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration

Liu, D., Webber, H. C., Bian, F., Xu, Y., Prakash, M., Feng, X., Yang, M., Yang, H., You, I.-J., Li, L., et al. (2024) · Nature Communications

Glaucoma and retinal disordersAmyotrophic Lateral Sclerosis Research

Cited by 34

Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration

Liu, D., Webber, H. C., Bian, F., Xu, Y., Prakash, M., Feng, X., Yang, M., Yang, H., You, I.-J., Li, L., et al. (2025) · Nature Communications

Glaucoma and retinal disordersAmyotrophic Lateral Sclerosis Research

Cited by 34